Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc.
ARQT
Valuace
70
Růst
63
Zdraví
75
Cena
$ 24.00
Dnes
--0.51 (-1.93%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.9B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-28%
ROA
-12%
PE
-187
PS
8
Cena 1R
11-32
⌀ Cena
19.05
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

Společnost Arcutis Biotherapeutics, Inc., biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci léčby dermatologických onemocnění. Jeho hlavním kandidátem je ARQ-151, topický roflumilastový krém, který dokončil klinické studie fáze III pro léčbu ložiskové psoriázy a atopické dermatitidy. Společnost také vyvíjí ARQ-154, což je lokální pěnová forma roflumilastu pro léčbu seborrheické dermatitidy a skalpové psoriázy; ARQ-252, selektivní lokální inhibitor januskinázy typu 1 pro ruční ekzém a vitiligo; a ARQ-255, lokální formulace ARQ-252 určená k proniknutí hlouběji do kůže za účelem léčby alopecií areata. Společnost byla dříve známá jako Arcutis, Inc. a v říjnu 2019 změnila své jméno na Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc. byla založena v roce 2016 a sídlí v Westlake Village v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
342
Založení
2020-01-31
Adresa
3027 Townsgate Road
CEO
Todd Franklin Watanabe

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017
Total Revenues376.1376.1196.559.63.70.00.00.00.00.0
Cost of Revenues36.736.719.15.00.80.00.00.00.00.0
Gross Profit339.4339.4177.454.62.90.00.00.00.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues129.599.281.565.871.444.830.949.613.538.1
Cost of Revenues11.78.77.58.86.95.53.53.32.41.2
Gross Profit117.890.574.057.064.539.327.446.311.136.9
Operating Income TTM 202520242023202220212020201920182017
R&D Expenses0.00.00.0110.6182.4145.6115.336.517.93.4
Selling General & Admin Expenses0.00.00.0185.1122.161.021.36.61.80.7
Depreciation & Amortization5.55.42.61.95.80.50.10.20.50.0
Total Operating Expenses351.6351.6305.8295.7304.6206.5136.643.119.74.1
Operating Income-12.2-12.2-128.4-241.1-301.6-206.5-136.6-43.1-19.7-4.1
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.023.826.2
Selling General & Admin Expenses0.00.00.00.00.00.00.00.048.547.6
Depreciation & Amortization1.30.60.63.10.51.40.40.40.40.4
Total Operating Expenses99.482.088.681.572.178.377.577.972.373.8
Operating Income18.48.5-14.6-24.5-7.6-39.1-50.1-31.6-61.2-36.9
Net Income TTM 202520242023202220212020201920182017
Interest Income0.00.00.00.00.00.00.00.00.00.0
Interest Expense12.112.127.229.715.70.00.00.00.00.0
Other Expense-2.7-2.7-11.0-17.9-9.80.21.01.10.5-0.9
IBT-15.0-15.0-139.4-259.0-311.5-206.4-135.7-42.0-19.3-5.0
Income Tax Expense1.21.20.63.19.8-0.50.00.0-0.50.0
Net Income-16.1-16.1-140.0-262.1-321.3-205.9-135.7-42.0-19.3-5.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.00.00.00.00.00.00.00.00.04.8
Interest Expense3.03.13.03.05.66.77.57.57.87.6
Other Expense-0.5-1.0-0.9-0.3-2.8-2.5-2.3-3.4-5.1-4.8
IBT17.97.5-15.5-24.8-10.5-41.5-52.3-35.1-66.3-41.7
Income Tax Expense0.50.10.30.30.30.00.00.30.03.0
Net Income17.47.4-15.9-25.1-10.8-41.5-52.3-35.4-66.3-44.8
Per Share Data TTM 202520242023202220212020201920182017
EPS$0.00$0.00$0.00$-3.78$-5.84$-4.17$-3.80$-1.20$-1.07$-0.28
EPS Diluted$0.00$0.00$0.00$-3.78$-5.84$-4.17$-3.80$-1.20$-1.07$-0.28
Shares Outstanding128.3127.2121.069.355.049.435.735.118.018.0
Diluted Shares Outstanding135.6127.2121.069.355.049.435.735.118.018.0
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.72$-0.73
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.72$-0.73
Shares Outstanding128.3127.6127.0126.0121.0124.3123.5111.092.661.7
Diluted Shares Outstanding135.6132.9127.0126.0121.0124.3123.5111.092.661.7
Current Assets TTM 20242023202220212020201920182017
Cash And Equivalents84.971.388.453.696.465.163.339.43.4
Short Term Investments278.2156.6183.5355.9290.6219.437.911.50.0
Total Cash & ST Investments363.1228.0271.9409.6387.1284.4101.350.93.4
Accounts Receivable43.473.125.88.50.40.50.00.00.0
Inventory13.914.513.17.51.2-0.50.00.00.0
Other Current Assets14.220.319.610.614.28.45.20.20.4
Total Current Assets434.6335.8330.4437.4402.8292.8106.551.13.8
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents47.173.053.171.3134.984.9190.789.3107.5105.1
Short Term Investments143.9118.1145.0156.6195.7278.2213.8183.5119.6163.6
Total Cash & ST Investments191.1191.1198.1228.0330.6363.1404.5272.8227.1268.7
Accounts Receivable115.1106.785.473.160.143.437.225.819.417.2
Inventory22.416.316.614.514.013.913.213.113.910.5
Other Current Assets20.618.623.620.319.014.913.819.621.112.5
Total Current Assets349.2332.8323.7335.8423.7434.6468.1330.4281.5308.9
Long-Term Assets TTM 20242023202220212020201920182017
Net Property, Plant & Equipment3.53.03.94.65.35.40.50.00.0
Goodwill0.00.00.00.00.00.00.00.00.0
Intangible Assets6.19.56.47.20.00.00.00.00.0
Long-Term Investments0.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.60.60.60.10.10.10.00.00.0
Total Long-Term Assets10.213.110.911.95.45.40.50.00.0
Total Assets444.8348.9341.4449.3408.2298.3107.051.13.8
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment5.83.13.33.03.23.53.63.94.24.4
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets15.415.916.59.59.86.16.36.46.66.8
Long-Term Investments0.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets0.60.60.60.60.60.60.60.60.60.6
Total Long-Term Assets21.819.720.413.113.610.210.510.911.411.8
Total Assets371.0352.4344.1348.9437.4444.8478.5341.4293.0320.7
Current Liabilities TTM 20242023202220212020201920182017
Accounts Payable7.914.212.08.87.47.11.41.80.5
Short-Term Debt0.80.81.50.70.40.00.20.00.0
Other Current Liabilities42.666.033.228.325.515.53.70.90.2
Current Liabilities51.481.046.737.833.322.65.22.70.7
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable5.815.124.514.219.37.913.012.013.217.2
Short-Term Debt1.01.00.80.8100.31.60.81.51.41.4
Other Current Liabilities93.087.965.866.052.841.933.633.227.318.1
Current Liabilities99.8103.991.181.0172.451.447.346.741.936.7
Long-Term Liabilities TTM 20242023202220212020201920182017
Long-Term Debt203.8109.8205.2201.977.15.00.10.00.0
Capital Leases3.03.44.14.85.25.00.30.00.0
Def. Tax Liability0.00.00.00.00.00.00.00.00.0
Total Liabilities258.3191.3252.7239.7110.527.6172.075.18.8
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt5.3109.2110.0109.8107.9206.8206.0205.2204.4203.5
Capital Leases5.32.13.23.43.63.03.23.44.34.5
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities212.9213.5201.4191.3280.7258.3253.6252.7246.2240.2
Total Common Equity TTM 20242023202220212020201920182017
Common Stock0.00.00.00.00.00.00.00.00.0
Retained Earnings-1,069.6-1,121.9-981.9-719.8-408.3-202.0-66.3-24.3-5.0
Comprehensive Income-0.30.00.0-1.1-0.30.00.00.00.0
Total Common Equity186.4157.588.7209.6297.7270.6-65.0-24.0-5.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-1,155.5-1,162.9-1,147.0-1,121.9-1,111.2-1,069.6-1,017.3-981.9-915.6-870.9
Comprehensive Income-0.10.0-0.10.00.5-0.3-0.10.0-0.2-0.3
Total Common Equity158.1139.0142.7157.5156.6186.4224.988.746.780.5
Other TTM 20242023202220212020201920182017
Total Debt207.6110.6205.9202.577.65.00.30.00.0
Book Value186.4157.588.7209.6297.7270.6-65.0-24.0-5.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value158.1139.0142.7157.5156.6186.4224.988.746.780.5
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017
Net Income-198.8-16.1-140.0-262.1-311.5-206.4-135.7-42.0-19.3-5.0
Depreciation & Amortization1.54.72.61.50.90.50.10.20.00.0
Stock-Based Compensation41.340.441.738.832.723.97.90.80.20.0
Change Working Capital-18.5-34.8-15.1-23.5-10.23.614.1-1.52.10.3
Change In Accounts Receivable-25.1-73.2-47.3-17.3-8.50.00.00.00.00.0
Change In Accounts Payable-9.3-1.72.23.21.60.25.7-0.51.30.5
Change In Inventories-3.4-7.3-0.4-5.6-7.50.00.00.00.00.0
Other Non-cash Items60.80.3-1.4-1.830.30.30.3-0.42.90.9
Cash from Operations-177.00.00.0-247.1-257.7-174.6-113.0-42.8-14.1-3.8
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income17.47.4-15.9-25.1-10.8-41.5-52.3-35.4-66.3-44.8
Depreciation & Amortization0.60.60.43.10.51.80.00.40.40.4
Stock-Based Compensation10.110.010.59.89.49.812.510.08.810.0
Change Working Capital-2.3-19.95.1-17.7-1.6-3.8-4.3-5.40.4-9.2
Change In Accounts Receivable-31.1-8.4-21.3-12.3-14.1-16.6-5.2-11.3-6.4-2.2
Change In Accounts Payable6.7-9.30.60.3-0.16.5-5.21.0-1.2-4.0
Change In Inventories0.0-5.90.5-2.0-0.30.6-0.6-0.10.8-3.4
Other Non-cash Items0.50.20.2-0.51.8-0.9-1.1-1.216.81.1
Cash from Operations0.00.00.00.00.00.00.00.0-56.2-44.0
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017
Capital Expenditure-0.1-0.7-0.1-0.4-23.3-1.0-0.3-0.30.00.0
Acquisitions16.60.00.00.023.00.00.00.00.00.0
Investments-372.3-247.0-254.8-225.8-415.4-292.5-279.1-60.8-11.50.0
Sales of Investment264.9227.4288.8406.5351.5217.697.634.80.00.0
Other Investing Activities-45.30.00.00.0-23.00.00.00.00.00.0
Cash from Investing-107.50.00.0180.2-87.2-76.0-181.8-26.3-11.50.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure0.00.0-0.1-0.6-5.0-0.10.00.00.0-0.1
Acquisitions0.00.00.00.00.00.00.00.062.2-45.6
Investments-89.2-68.5-33.2-56.1-17.4-5.7-125.8-106.0-118.2-22.4
Sales of Investment55.043.360.768.557.390.663.677.356.068.0
Other Investing Activities0.00.00.00.00.00.00.00.0-62.245.6
Cash from Investing0.00.00.00.00.00.00.00.0-62.245.5
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued3.3110.6-95.33.4125.072.64.70.30.00.0
Issuance of Common Stock263.40.00.098.9176.0207.5297.094.20.00.0
Repurchase of Common Stock0.00.00.00.012.50.80.60.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities100.20.00.02.4113.373.60.5-1.161.67.1
Cash from Financing263.40.00.0101.3301.8281.9298.193.161.67.1
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued6.3-103.9-0.60.2-97.60.60.80.80.80.9
Issuance of Common Stock0.00.00.00.00.00.00.00.098.90.9
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.40.9
Cash from Financing0.00.00.00.00.00.00.00.099.30.9
Cash position TTM 202520242023202220212020201920182017
Net Change in Cash-21.2-28.7-17.434.4-43.131.43.323.936.03.3
Closing Cash Balance84.943.272.089.354.998.066.663.339.43.4
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-4.2-25.619.3-18.2-63.550.6-105.8101.4-19.12.4
Closing Cash Balance43.247.473.053.772.0135.584.9190.789.3108.4
Free Cash Flow TTM 202520242023202220212020201920182017
Free Cash Flow-177.0-6.3-112.3-247.5-281.0-175.6-113.4-43.1-14.1-3.8
Real Free Cash Flow-218.3-46.7-154.0-286.3-313.7-199.5-121.3-44.0-14.2-3.8
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow26.2-1.80.2-31.0-5.7-34.8-45.1-31.6-56.3-44.0
Real Free Cash Flow16.1-11.8-10.2-40.8-15.1-44.6-57.6-41.6-65.0-54.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-186.6-14.5-1.4
P/S876.39.4
P/B19.16.55.2
P/FCF-64.5-10.5-1.5
Market cap$2.9$6.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets1.7 %23 %0 %
Debt to Income-38.9 %-40.3 %0 %
Debt to Free cash flow-13.4 %-2379.6 %0 %
Interest expense percentage-98.8 %-6.9 %44.7 %
Current ratio3.5 10.9 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-10.2 %-101.8 %0 %
ROA-4.4 %-50 %0 %
CapEx to Revenue1.8 %158.4 %0 %
RaD to Revenue0 %1342.6 %0 %
ROEM1,099,625.7 29674.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin90 %39.8 %68.7 %
Operating margin-12 %-2117.8 %35.5 %
Net margin-13.9 %-2220.8 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding132.9 mil 60.1 mil
Employee count0.3 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader